6CQ.F 0.9 (-2.17%)
CA22587M1068Drug ManufacturersDrug Manufacturers - Specialty & Generic

Cresco Labs (6CQ.F) Competitor Comparison

We are evaluating the key criteria listed to compare Cresco Labs (6CQ.F) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 5 years - 6CQ.F ranking 0 / 54

These are the competitors of Cresco Labs in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 5 years
1. Phibro Animal Health PAHC
52.92
2. ProPhase Labs PRPH
32.25
3. ANI Pharmaceuticals ANIP
25.05
4. Green Thumb Industries R9U2.F
21.33
5. Evolus EOLS
18.84
6. Catalent CTLT
14.84
7. Organogenesis Holdings ORGO
13.52
8. Regencell Bioscience Holdings RGC
12.53
9. Alvotech ALVO
10.25
10. Neoleukin Therapeutics NLTX
8.58
11. Kamada KMDA
8.09
12. Alimera Sciences ALIM
7.82
13. Vifor Pharma G2AB.F
7.23
14. Avadel Pharmaceuticals AVDL
7.15
15. PetIQ PETQ
6.43
16. Zoetis ZTS
5.81
17. Kolinpharma KIP.MI
4.88
18. Linc LNC
4.81
19. Pacira BioSciences PCRX
4.53
20. Curaleaf Holdings CURLF
4.21
21. Perrigo PRGO
4.17
22. Journey Medical DERM
3.93
23. Elanco Animal Health ELAN
3.75
24. Ayr Wellness 3KJB.F
3.71
25. Taro Pharmaceutical Industries TARO
3.55
26. Collegium Pharmaceutical COLL
3.43
27. Ironwood Pharmaceuticals IRWD
3.37
28. Embecta EMBC
3.06
29. Cronos Group CRON
2.83
30. Supernus Pharmaceuticals SUPN
2.82
31. Emergent BioSolutions EBS
2.81
32. Procaps Group PROC
2.59
33. Bausch Health Companies BHC
2.48
34. Zynerba Pharmaceuticals ZYNE
2.47
35. Jupiter Wellness JUPW
2.39
36. Theratechnologies THTX
2.37
37. Cumberland Pharmaceuticals CPIX
2.29
38. SCYNEXIS SCYX
2.27
39. Societal CDMO SCTL
2.21
40. Eagle Pharmaceuticals EGRX
2.19
41. Relmada Therapeutics RLMD
2.06
42. Alpha Teknova TKNO
1.96
43. Solid Biosciences SLDB
1.94
44. Clever Leaves Holdings CLVR
1.87
45. Tilray Brands TLRY
1.84
46. OptiNose OPTN
1.83
47. Ascend Wellness Holdings AAWH
1.77
48. Biofrontera BFRI
1.74
49. Teva Pharmaceutical Industries TEVA
1.69
50. Flora Growth FLGC
1.63
51. Universe Pharmaceuticals UPC
1.61
52. Amphastar Pharmaceuticals AMPH
1.58
53. Amneal Pharmaceuticals AMRX
0.89
54. Harrow Health HROW
0.38

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.